Antitumoral compounds from vertebrate sister group: A review of Mediterranean ascidians

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Among the diseases that afflict the human population, cancer is one for which many drug treatments are not yetknown or effective. Moreover, the pharmacological treatments used often create serious side effects in sickpatients and for this reason, it is essential to find effective and less harmful treatments. To date, marine biodiversity is a real source of metabolites with antitumoral activity and among invertebrates’ ascidians have been the main source to obtain them. Mediterranean area is the richest in biodiversity and contains several ascidian species used in drugs development during the years. However, many more Mediterranean ascidian species have not been studied and could be a source of useful bioactive compounds. This review aims to summarize the scientific studies that analyzed the antitumor compounds obtained from different Mediterranean ascidians species, encouraging them to search further compounds in other new species to improve pharmacological treatments and human population life.
Original languageEnglish
Number of pages17
JournalDevelopmental and Comparative Immunology
Publication statusPublished - 2020

All Science Journal Classification (ASJC) codes

  • Immunology
  • Developmental Biology

Fingerprint Dive into the research topics of 'Antitumoral compounds from vertebrate sister group: A review of Mediterranean ascidians'. Together they form a unique fingerprint.

Cite this